These data do not support the biosynthetic pathway leading to gentamicin C2b proposed by Testa and Tilley.
Testa and Tilley (6) incubated Micromonospora purpurea Paro 346, a mutant blocked in gentamicin formation, with gentamicins A, X2, JI-20A, C0i, G-418, JI-20B, and C2, respectively, and showed chromatographic evidence for biotransformations of the substrates: A to bioactive spots corresponding to Cl., C2, and Cl; X2 to Cl0, C2, and Cl-like spots; G-418 to C2 and Cl-like spots; JI-20B to C2 and Cl-like spots; and C2 to a Cl-like spot. Based on these preliminary chromatographic data, they proposed a biosynthetic pathway for the gentamicins: (i) paromamine to gentamicin A and then to gentamicin X2. (ii) From gentamicin X2, the pathway is branched into two; one pathway leads to JI-20A, Cl., and then C2b; the second pathway leads to G-418, JI-20B, C2 and then Cl.
None of the internediates or products was isolated and characterized in their work, and chromatographic evidence which corresponded to all of the intermediates involved was not provided. Furthermore, direct evidence was not given to show conversion of paromamine to spots corresponding to all of the antibiotics mentioned in their proposed biosynthetic pathway.
Daniels and co-workers reported on the production of gentamicin C2b by a M. purpurea mutant and on the isolation and characterization of the antibiotic (1). Japanese workers published data on sagamicin (5), which was found to be identical to gentamicin C2b, and subsequently on the biosynthesis of '4C,3H-labeled sagamicin (2 (3) .
In the present investigation we used two M. Coluimn chromatography. For column chromatographic separation, 1,160 mg of the crude antibiotic mixture isolated from incubation of strain SC 1210 was charged onto 70 ml of CG-50 resin (in NH4' cycle) packed in a column (4 by 40 cm). The products were obtained by elution of the column successively with the following aqueous ammonia solutions: 300 ml each of 0.1 and 0.12 N, 500 ml of 0.14 N, and 2,000 ml of 0.16 N. The flow rate of the elution was approximately 10 ml/2.5 min.
For separation of products from the fermentation of mutant SC 1124, the isolated crude mixture (1, 036 mg) was applied onto 70 ml of CG-50 resin (in NH4' cycle) packed in a column (4 by 40 cm). Products were eluted similarly as in the previous chromatography. (Table 1) .
A 10-liter fermentation of mutant SC 1124, with 41 mg of [methyl-14C]JI-20A containing radioactivity of 4.2 x 106 dpm and 500 mg of unlabeled JI-20A, yielded 1,036 mg of a crude antibiotic mixture possessing radioactivity of 2.7
x 106 dpm. The crude mixture was chromatographed on ion-exchange resin: elution with 0.2 N aqueous ammonia solution yielded 214 mg of JI-20A, whereas elution with 0.28 N aqueous ammonia solution gave 22 mg of gentamicin C2b and 6 mg of gentamicin C a, respectively. Specific radioactivities determined for the JI-20A added and the two transformed products, gentamicin Cl. and gentamicin C2b, were 3,750, 2,919, and 3,503 dpm/,umol, respectively. These results gave a molar radioactivity ratio of 10:8:9 for the JI-20A added:gentamicin Cla transformed:gentamicin C2b transformed ( Table 2 ). In two subsequent experiments the ratio obtained varied from 10:7:8 to 10:3:8.
In 
